Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From IHUB and NDOC

"HTC counters that the ITC investigation, in particular the ALJ’s initial determination and the Staff Attorney’s positions, constitute objective evidence that HTC should be able to rely upon

..."to overcome a charge of ...willful infringement".

TPL’s motion to exclude evidence of the co-pending ITC investigation is GRANTED"...

----------------------------------------------------

Notice that it does NOT state for purposes of determininmg infringement,,'PER SE',,

But for "Willful".infringement.

Are they anticipating a ruling against HTC/themselves? And are actually trying to head-off

a possible enhanced damages scenario.?

Trying to read the 'TEA LEAVES'.

Share
New Message
Please login to post a reply